![]() |
| Audrey and Grandpa playing checkers at Vanderbilt. |
Are you ready,
Are you ready for this
Are you hanging on the edge of your seat
Yep, another chemo bites the dust.
Don has spent a grand total of 375 days on Inlyta chemotherapy. It worked good for us, up until the last CT scan. For one year we had the tumors shrink and stable, however, our scan on April 5, 2013 showed that we have growth on only his bones. The tumors in his lungs and left kidney are all stable. This means that Inlyta has run its course and Don's kidney cancer has become immune to this therapy. So, when that happens, we turn to something else.
- Right fourth rib soft tissue mass extends into the adjacent lung. Previously measured 2.2 cm x 8 mm and has increased to 2.5 cm x 1.9 cm.
- Spleen, liver and pancreas is unchanged.
- Left kidney is stable
- Lesion on the anterolateral third rib on left measures 1.8 cm and previously measured 1.1 cm.
- Lesion on eighth rib is stable.
- Lesion in L4 has increased in size from mm to 1.2 cm.
- Lesion in the right acetabulum has disrupted the quadrilateral plate and extends into the anterior lip of the mediastinum and has increased in size and measures 2.5 cm in maximum diameter.
Having the cancer grow is scary. It's the worse case scenario that runs through your head that makes it even
After my breakdown I called Don and told him the results of the CT scan and his reaction was nothing like mine. His reply is "It's not as bad as I thought". Here I breakdown and wait for the sky to fall and Don takes it with a grain of salt. His reaction to the news helped calm me. He said to get out a ruler and look at how big a centimeter is. Apparently Don was expecting news that his tumors had gone to his liver, etc. and while going to the bone is bad, it isn't horrible.
So, knowing that Inlyta had run its course, we were off to have a follow-up appt. with Dr. Puzanov. We met with him and were given two options: a Phase 1 Dosing Escalation Study on a non-FDA approved drug called MLN0128 or a drug called Afinitor. Both are mTOR inhibitors (Mammalian target of rapamycin (mTOR) inhibitors block the activity of the mammalian target of rapamycin. Mammalian target of rapamycin is a protein kinase, which regulates growth factors that stimulate cell growth and angiogenesis. In certain cancers the mTOR pathway is more active. Mammalian target of rapamycin (mTOR) inhibitors are used in treatment of renal cancer and is being studied for use in other types of cancers.) We know that since the cancer has stopped responding to Inlyta, that we have to switch up the chemotherapy and confuse it. Therefore, we have to switch to a mTOR inhibitor drug.
After a full weekend of thinking it over, weighing the pros and cons, Don made the decision to fore go going onto the Clinical Study and to switch over to Afinitor.
![]() |
| We aren't sure of the side effects of Afinitor, but expect them to be like Sutent & Inlyta. |
The cancer cells & the blood vessels that help feed the cancer cells.
As a result, AFINITOR: May slow the growth and spread of kidney cancer. Can restrict cancer cells from getting the nutrition they need to grow. May slow the blood vessels from growing and supplying the tumor with blood. AFINITOR may also affect healthy, non-tumor cells.
So, we are onto our fourth chemotherapy in 4 years & 4 months since diagnosis. We have done (in order) Sutent, Avastin/Torisel Clinical Study and Inlyta. It is scary starting a new drug, with new side effects and to wait until a CT scan to see if it is working, however, we have been there, and done that 3 times now. Seems like we would be used to it, but nope! Each time is just as scary as the first time.
So, any day now a package will arrive at my office and that one package with 90 pills will be worth an estimated $24,840 for 3 months of chemotherapy. Thankfully we only will pay a grand total of $86.00 and for that we are eternally thankful. Without Don's insurance we would not be able to keep Don alive! Seriously, as morbid as that sounds, we wouldn't. His insurance is a blessing and his work is a blessing.
![]() |
Chattanooga Pow Wow ~ Don danced in the
Honoring of Veterans |
So, in a nut shell this is where we are. Starting all over with a new set of tumors that present new problems and a new drug that will present new issues as well. One issue Don is looking forward to is that this new drug will allow him to gain some of his weight back. The Inlyta had him shrinking like crazy ... I was expecting to shop for him in the Junior department before too long (OK ... I joke, but seriously he has bony legs and butt now!)
Thank you to those that have read this all and thank you to those of you that really care. Your texts, emails and phone calls are what support us. You really find out who your friends are when you have a prolonged illness. There are those that are supportive in the beginning, and then you have those friends that are there all along ... supportive from the beginning, those are real friends and we are thankful for you. You help us get through this day-by-day.
Until next time ......

































